Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

In Response to Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2026
Same author

When to assess responses to treatments in adaptive interventions? An experimental analysis of assessment timing in a smoking cessation treatment in the context of lung cancer screening.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026
Same author

Cancer Prevention/Interception Agent Development.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.

The Laryngoscope·2025
Same author

Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.

American journal of respiratory and critical care medicine·2025
Same author

Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement.

American journal of respiratory and critical care medicine·2023

相关实验视频

Updated: Sep 17, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

基于证据的肺癌查在一个量身定制的包装.

Abbie Begnaud1, Frank G Ondrey2,3

  • 1Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Lung Cancer Screening Program, University of Minnesota Health, Minneapolis, Minnesota.

Cancer prevention research (Philadelphia, Pa.)
|July 1, 2025
PubMed
概括

部落参与的肺部查方法 (TEALS) 研究改善了高风险的美国印第安人/阿拉斯加土著人的肺癌查. 这种部落参与方法成功地提高了巧克塔民族内的查率.

更多相关视频

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K

相关实验视频

Last Updated: Sep 17, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K

科学领域:

  • 公共卫生 公共卫生
  • 预防癌症 预防癌症
  • 健康差异 在健康上的差异

背景情况:

  • 癌症查对于预防和早期检测至关重要,但边缘化人口面临着进入障碍.
  • 提高癌症查率,特别是肺癌,仍然是一个重大的公共卫生挑战.
  • 需要有针对性的干预措施来解决癌症查获取和采用方面的差异.

研究的目的:

  • 评估Tribally Engaged Approaches to Lung Screening (TEALS) 研究的有效性. 这项研究旨在评估Tribally Engaged Approaches to Lung Screening (TEALS) 研究的有效性.
  • 提高高风险的美国印第安人/阿拉斯加原住民肺癌查率.
  • 评估一个以社区为基础的癌症查方法在Choctaw民族.

主要方法:

  • 实施TEALS研究,一个全面的肺癌查计划.
  • 专注于俄克拉荷马州美国印第安人/阿拉斯加土著社区的高风险人口.
  • 利用部落参与的方法来促进查访问和参与.

主要成果:

  • TEALS研究显著改善了符合条件的个体的肺癌查率.
  • 与巧克塔民族社区的成功接触提高了查的普及率.
  • 证明了文化定制查干预措施的可行性.

结论:

  • 部落参与的方法有效地提高了美国印第安人/阿拉斯加土著人口的肺癌查率.
  • 具体的社区战略可以克服边缘化群体癌症查的障碍.
  • TEALS研究为改善土著社区癌症预防工作提供了一个模型.